Immunologic Reactions of Lepromatous Leprosy

Thomas Robert Swift, Byron H. Waksman

Research output: Contribution to journalLetter

Abstract

To the Editor: In his recent editorial, Waksman (N Engl J Med 286:431–432, 1972), in discussing measurement of cell-mediated immunity (CMI), makes reference to dysfunction of the CMI system as being responsible for reaction in lepromatous leprosy (known as erythema nodosum leprosum or ENL). Although patients with lepromatous leprosy have defective CMI,14 which may be one factor responsible for the development of lepromatous disease in the first place,5 the specific immunologic reaction referred to in the editorial is mediated by the humoral antibody system. Antibody reacts with excess mycobacterial antigen from dead bacilli. In a zone of “excess antigen” these.

Original languageEnglish (US)
Number of pages1
JournalNew England Journal of Medicine
Volume286
Issue number16
DOIs
StatePublished - Apr 20 1972

Fingerprint

Lepromatous Leprosy
Cellular Immunity
Erythema Nodosum
Antigens
Antibodies
Bacillus

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Immunologic Reactions of Lepromatous Leprosy. / Swift, Thomas Robert; Waksman, Byron H.

In: New England Journal of Medicine, Vol. 286, No. 16, 20.04.1972.

Research output: Contribution to journalLetter

@article{d221fde146ab41a9ae19e991f1aeda6e,
title = "Immunologic Reactions of Lepromatous Leprosy",
abstract = "To the Editor: In his recent editorial, Waksman (N Engl J Med 286:431–432, 1972), in discussing measurement of cell-mediated immunity (CMI), makes reference to dysfunction of the CMI system as being responsible for reaction in lepromatous leprosy (known as erythema nodosum leprosum or ENL). Although patients with lepromatous leprosy have defective CMI,14 which may be one factor responsible for the development of lepromatous disease in the first place,5 the specific immunologic reaction referred to in the editorial is mediated by the humoral antibody system. Antibody reacts with excess mycobacterial antigen from dead bacilli. In a zone of “excess antigen” these.",
author = "Swift, {Thomas Robert} and Waksman, {Byron H.}",
year = "1972",
month = "4",
day = "20",
doi = "10.1056/NEJM197204202861617",
language = "English (US)",
volume = "286",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "16",

}

TY - JOUR

T1 - Immunologic Reactions of Lepromatous Leprosy

AU - Swift, Thomas Robert

AU - Waksman, Byron H.

PY - 1972/4/20

Y1 - 1972/4/20

N2 - To the Editor: In his recent editorial, Waksman (N Engl J Med 286:431–432, 1972), in discussing measurement of cell-mediated immunity (CMI), makes reference to dysfunction of the CMI system as being responsible for reaction in lepromatous leprosy (known as erythema nodosum leprosum or ENL). Although patients with lepromatous leprosy have defective CMI,14 which may be one factor responsible for the development of lepromatous disease in the first place,5 the specific immunologic reaction referred to in the editorial is mediated by the humoral antibody system. Antibody reacts with excess mycobacterial antigen from dead bacilli. In a zone of “excess antigen” these.

AB - To the Editor: In his recent editorial, Waksman (N Engl J Med 286:431–432, 1972), in discussing measurement of cell-mediated immunity (CMI), makes reference to dysfunction of the CMI system as being responsible for reaction in lepromatous leprosy (known as erythema nodosum leprosum or ENL). Although patients with lepromatous leprosy have defective CMI,14 which may be one factor responsible for the development of lepromatous disease in the first place,5 the specific immunologic reaction referred to in the editorial is mediated by the humoral antibody system. Antibody reacts with excess mycobacterial antigen from dead bacilli. In a zone of “excess antigen” these.

UR - http://www.scopus.com/inward/record.url?scp=0015516818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015516818&partnerID=8YFLogxK

U2 - 10.1056/NEJM197204202861617

DO - 10.1056/NEJM197204202861617

M3 - Letter

C2 - 5061083

AN - SCOPUS:0015516818

VL - 286

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 16

ER -